Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schäfer-Korting

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
ALTEX|December 7, 2000
[Tridimensional skin models recording percutaneous absorption]Gysler, Königsmann, Schäfer-Korting
Pharmazie in Unserer Zeit|April 8, 2003
[A silver lining on the horizon: new antimycotics]Monika Schäfer-Korting, Ulrike Holzgrabe
Mycoses|January 1, 1997
[Effect of keratin on the efficacy of fluconazole]K Klimke, M Schäfer-Korting
Handbook of Experimental Pharmacology|September 7, 2020
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug DevelopmentMonika Schäfer-Korting, Christian Zoschke
Journal of Chromatography|July 9, 1982
Fluorodensitometric determination of nadolol in plasma and urineM Schäfer-Korting, E Mutschler
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazineM Schäfer-Korting, E Mutschler
Pharmazie in Unserer Zeit|April 8, 2003
[Antimycotics]Ulrike Holzgrabe, Monika Schäfer-Korting
Pharmazie in Unserer Zeit|August 6, 2003
[Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment]Monika Schäfer-Korting, Hans-Christian Korting
Archives of Dermatological Research|January 1, 1982
Intraindividual variations of 8-methoxypsoralen plasma levelsM Schäfer-Korting, H C Korting
Handbook of Experimental Pharmacology|March 11, 2010
Carriers in the topical treatment of skin diseaseHans Christian Korting, Monika Schäfer-Korting
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
ALTEX|December 7, 2000
[Tridimensional skin models recording percutaneous absorption]Gysler, Königsmann, Schäfer-Korting
Pharmazie in Unserer Zeit|April 8, 2003
[A silver lining on the horizon: new antimycotics]Monika Schäfer-Korting, Ulrike Holzgrabe
Mycoses|January 1, 1997
[Effect of keratin on the efficacy of fluconazole]K Klimke, M Schäfer-Korting
Handbook of Experimental Pharmacology|September 7, 2020
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug DevelopmentMonika Schäfer-Korting, Christian Zoschke
Journal of Chromatography|July 9, 1982
Fluorodensitometric determination of nadolol in plasma and urineM Schäfer-Korting, E Mutschler
European Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazineM Schäfer-Korting, E Mutschler
Pharmazie in Unserer Zeit|April 8, 2003
[Antimycotics]Ulrike Holzgrabe, Monika Schäfer-Korting
Pharmazie in Unserer Zeit|August 6, 2003
[Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment]Monika Schäfer-Korting, Hans-Christian Korting
Archives of Dermatological Research|January 1, 1982
Intraindividual variations of 8-methoxypsoralen plasma levelsM Schäfer-Korting, H C Korting
Handbook of Experimental Pharmacology|March 11, 2010
Carriers in the topical treatment of skin diseaseHans Christian Korting, Monika Schäfer-Korting
Pageof 22